Kerry Rowe, PhD, is a senior medical informaticist at Intermountain Healthcare. His work is focused on cancer genomics and quality care improvement and outcomes in cancer care. He participates on a variety of projects including iCentra implementation for oncology, cancer genomics clinical and research applications, oncology care pathways, and bone marrow transplant management software implementation.
Dr. Rowe has a BA in Applied Mathematics from Weber State University, a MS in Medical Informatics from the University of Utah, and a PhD in Medical Informatics from the University of Utah School of Medicine. He is a member of the American Medical Informatics Association and the American Society of Clinical Oncology.
Areas of Focus
- Use of electronic data systems to improve oncology care
- Genomic sequencing of biorepository cancer specimens
- Intermountain Healthcare lead for Utah Population Database (UPDB) projects
Significance to Patient Care
Much of Dr. Rowe's work centers around the implementation of electronic medical records systems used in cancer care. He has been working with his team to develop chemotherapy regimens in iCentra that will be used by medical oncologists to treat cancer patients. There are more than 200 regimens built into iCentra Powerplans. In addition, Dr. Rowe and his team will develop additional Powerplans for pediatric oncology and bone marrow transplant units. He is involved in implementing oncology care pathways that will be used to guide cancer care. He also works closely with the oncology clinical program and a number of physicians on quality improvement projects and outcomes studies.
Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter W, Skolnick MH: Familiality of cancer in Utah. Cancer Research. 54:2378-2385, 1994. PMID: 8162584.
Rowe KG: Record Linking and Genetic Analysis of Utah Death Certificates. Doctoral Dissertation. 1996.
Rowe KG, Cannon-Albright LA, Lewis CM, Mineau G, Skolnick HM: Genetic Analysis by Common Cause of Death Using Death Certificates Linked to a Population Database.(abs.) The American Journal of Human Genetics. 59(4):A188,1996.
Abkevich V, Camp NJ, Hensel CH, Neff CD, CD Russell CD, Hughes DC, Plenk A, Lowry M, Richards RL, Carter C, Frech GC, Stone S, Rowe K, Chau C, Cortado K, Hunt A, Luce K, O’Neil G, Poarch J, Potter J, Poulsen G, Saxton H, Sestak M, Thompson V, Gutin A, Skolnick MH, Shattuck D, Cannon-Albright L: (2003) Predisposition Locus for Major Depression at chromosome 12q22- 12q23.2. The American Journal of Human Genetics 73(6):1271-81, 2003. PMID: 14606042.
Rowe K, Hammond E, Nkoy F: Standardized Data Entry for Pathology Reporting Facilitates Outcomes Research and Quality Improvement in Cancer Care (abs). Frontiers in Oncology and Pathology Informatics (APIII) (2004).
Nkoy F, Rees W, Sause W, Hammond E, Pinto K, Rowe K: Decision Making Process for Early- State Breast Cancer is Surgeon Driven. (abs). San Antonio Breast Cancer Symposium (2005).
Whisenant J, Belnap T, Rowley B, Alleman K, Rowe K, Jones C, Sause W: Practice Standardization in the Staging and Treatment of Colon Cancer at Intermountain Healthcare (abs) American Society of Clinical Oncology Annual Meeting (2010).
Seger HM, Soisson AP, Dodson MK, Rowe KG, Cannon-Albright LA: Familial clustering of endometrial cancer in a well-defined population. Gynecologic Oncology 2011 Jul;122(1):75-8.
Tuohy TM, Rowe KG, Mineau GP, Pimentel R, Burt RW, Samadder NJ. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah. Cancer. 2014 Jan 1;120(1):35-42.. Epub 2013 Oct 21.
Samadder NJ, Curtin K, Tuohy TM, Pappas L, Boucher K, Provenzale D, Rowe KG, Mineau GP, Smith K, Pimentel R, Kirchhoff AC, Burt RW: Characteristics of Missed or Interval Colorectal Cancer and Patient Survival: A Population-Based Study. Gastroenterology. 2014 Apr;146(4):950-60.